PP_1170x120_10-25-21

Voltaren Arthritis Pain

Voltaren Arthritis Pain and the Arthritis Foundation announce multi-year partnership

Voltaren Arthritis Pain and the Arthritis Foundation announce multi-year partnership

WARREN, N.J.— GlaxoSmithKline recently announced a multi-year partnership with the Arthritis Foundation to support scientific research, advocacy as well as virtual resources and community connections for the more than 30 million people in America living with osteoarthritis (OA). As part of the mission for an osteoarthritis cure, Voltaren Arthritis Pain is donating 100% of profits

FDA approves GSK’s Voltaren Arthritis Pain for O-T-C use

FDA approves GSK’s Voltaren Arthritis Pain for O-T-C use

WARREN, N.J. — GlaxoSmithKline announced Tuesday that the U.S. Food and Drug Administration (FDA) has approved Voltaren Arthritis Pain (diclofenac sodium topical gel, 1% (NSAID)- arthritis pain reliever) as an over-the-counter (O-T-C) product for the temporary relief of arthritis pain in the hand, wrist, elbow, foot, ankle or knee in adults (18 years and older).  With

Adheris Health